CNTB: the cash flow

MyFinsight

Cash Flow	2025-12-31
License and collaboration revenues	64
Research and development expense	37,798
General and administrative expense	20,340
Other income, net	2,791
Income tax expense	197
Net loss	-55,480
Share-based compensation expense	3,726
Depreciation and amortization	704
Accretion of discounts on available-for-sale investments	773
Impairment of property and equipment	0
Loss on disposal of property and equipment	-37
Accounts receivable, net	-776
Prepaid expenses and other current assets	4,110
Other non-current assets	605
Accounts payable	1,622
Accrued liabilities	3,358
Contract liabilities	3
Operating lease liabilities	54
Other non-current liabilities	-518
Net cash used in operating activities	-51,206
Purchases of short-term investments	30,470
Proceeds from maturities and sales of short-term investments	40,720
Purchases of property and equipment	434
Proceeds from sale of property and equipment	2
Net cash provided by (used in) investing activities	9,818
Proceeds from shares issued under the employee share purchase plan	218
Proceeds from exercise of stock options	875
Net cash provided by financing activities	1,093
Effect of exchange rate changes on cash and cash equivalents	408
Net decrease in cash and cash equivalents	-39,887
Cash and cash equivalents at beginning of year	78,232
Cash and cash equivalents at end of year	38,345

Unit: Thousand (K) dollars (except for numbers of shares and EPS).